Cargando…

Estimating the Cost-Effectiveness of One-Time Screening and Treatment for Hepatitis C in Korea

BACKGROUND AND AIMS: This study aims to investigate the cost-effectiveness of a one-time hepatitis C virus (HCV) screening and treatment program in South Korea where hepatitis B virus (HBV) prevails, in people aged 40–70, compared to current practice (no screening). METHODS: A published Markov model...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Do Young, Han, Kwang-Hyub, Jun, Byungyool, Kim, Tae Hyun, Park, Sohee, Ward, Thomas, Webster, Samantha, McEwan, Phil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5218507/ https://www.ncbi.nlm.nih.gov/pubmed/28060834 http://dx.doi.org/10.1371/journal.pone.0167770

Ejemplares similares

Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus
por: McEwan, Phil, et al.
Publicado: (2017)

Estimating the Clinical and Economic Benefit Associated with Incremental Improvements in Sustained Virologic Response in Chronic Hepatitis C
por: McEwan, Phil, et al.
Publicado: (2015)

Epidemiological and Clinical History of Viral Hepatitis in Korea
por: Yoon, Jung-Hwan, et al.
Publicado: (2021)

Estimation of direct medical cost related to the management of chronic hepatitis C and its complications in South Korea
por: Kim, Do Young, et al.
Publicado: (2016)

Estimating HIV Management and Comorbidity Costs Among Aging HIV Patients in the United States: A Systematic Review
por: Ward, Thomas, et al.
Publicado: (2020)

Strategic Distributional Cost-Effectiveness Analysis for Improving National Cancer Screening Uptake in Cervical Cancer: A Focus on Regional Inequality in South Korea
por: Lee, Tae-Hoon, et al.
Publicado: (2018)

Combined effect of body mass index and body size perception on metabolic syndrome in South Korea: results of the fifth Korea National Health and Nutrition Examination Surveys (2010-2012)
por: Yoon, Sook Hee, et al.
Publicado: (2015)

Cost Effectiveness of Screening for Hepatitis C Virus in Iraq in the Era of Simplified Testing and Treatment
por: Asker, Bassem, et al.
Publicado: (2021)

Conditional Survival Estimates Improve Over Time for Patients with Hepatocellular Carcinoma: An Analysis for Nationwide Korea Cancer Registry Database
por: Lee, Jae Seung, et al.
Publicado: (2019)

Consumption of pharmaceutical drugs in exception region of separation for drug prescribing and dispensing program in South Korea
por: Yuk, Sang Mi, et al.
Publicado: (2015)

Cost effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalaemia in patients with CKD in Norway and Sweden
por: Kim, Kun, et al.
Publicado: (2022)

Emerging Therapies for Hepatitis C
por: Kim, Do Young, et al.
Publicado: (2014)

Cost-Effectiveness Analysis of Hypertension Screening in the Korea National Health Screening Program
por: Lee, Hae-Young, et al.
Publicado: (2021)

The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-on Therapy to Metformin in Patients with Uncontrolled Type 2 Diabetes Mellitus
por: Gordon, Jason, et al.
Publicado: (2016)

Changes in Saturday outpatient volume and billings after introducing the Saturday incentive programme to clinics in South Korea: a longitudinal cohort study using claims data from 2012 to 2014
por: Ha, Hyun Ji, et al.
Publicado: (2016)

A tool to measure the impact of inaction toward elimination of hepatitis C: A case study in Korea
por: Won, Yong Kyun, et al.
Publicado: (2020)

The costs of hepatitis A infections in South Korea
por: Kim, Kyohyun, et al.
Publicado: (2014)

Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period: A nationwide random sample study
por: Kim, Beom Kyung, et al.
Publicado: (2019)

Cost-effectiveness of scaling up of hepatitis C screening and treatment: a modelling study in South Korea
por: Kim, Jungyeon, et al.
Publicado: (2019)

Cost-effectiveness of chronic hepatitis C screening and treatment
por: Lee, Hye Won, et al.
Publicado: (2022)

Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis B
por: Lee, Sangheun, et al.
Publicado: (2015)

Diabetes screening in South Korea: a new estimate of the number needed to screen to detect diabetes
por: Ha, Kyoung Hwa, et al.
Publicado: (2023)

Occupational Hepatic Disorders in Korea
por: Kim, Hyoung Ryoul, et al.
Publicado: (2010)

Transient elastography-based risk estimation of hepatitis B virus-related occurrence of hepatocellular carcinoma: development and validation of a predictive model
por: Kim, Do Young, et al.
Publicado: (2013)

Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naïve chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort
por: Ahn, Sung Soo, et al.
Publicado: (2014)

Resource use and direct medical costs of acute respiratory illness in the UK based on linked primary and secondary care records from 2001 to 2009
por: Meier, Geneviève C., et al.
Publicado: (2020)

Cost-Utility Analysis of Screening Strategies for Diabetic Retinopathy in Korea
por: Kim, Sang-Won, et al.
Publicado: (2015)

External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions
por: Lopes, Sandra, et al.
Publicado: (2020)

A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective
por: Kim, Hye-Lin, et al.
Publicado: (2022)

Efficacy and Long-Term Follow Up of Combination Therapy with Interferon Alpha and Ribavirin for Chronic Hepatitis C in Korea
por: Kim, Jie-Hyun, et al.
Publicado: (2006)

The Effects of Temperature on Heat-related Illness According to the Characteristics of Patients During the Summer of 2012 in the Republic of Korea
por: Na, Wonwoong, et al.
Publicado: (2013)

Estimation of Direct Medical Costs Related to Chronic Hepatitis C: A Rationale for Early Antiviral Therapy
por: Kim, Do Young
Publicado: (2017)

Authors’ reply to Comment on “External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions”
por: Lopes, Sandra, et al.
Publicado: (2020)

Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies
por: Pochopien, Michal, et al.
Publicado: (2019)

Hepatitis C Virus and Antiviral Drug Resistance
por: Kim, Seungtaek, et al.
Publicado: (2016)

Assessing the Long-Term Impact of Treating Hepatitis C Virus (HCV)-Infected People Who Inject Drugs in the UK and the Relationship between Treatment Uptake and Efficacy on Future Infections
por: Bennett, Hayley, et al.
Publicado: (2015)

Lifetime survival and medical costs of lung cancer: a semi-parametric estimation from South Korea
por: Park, Hae-Young, et al.
Publicado: (2020)

Estimating the Fiscal Costs of Osteoporosis in Korea Applying a Public Economic Perspective
por: Connolly, Mark P., et al.
Publicado: (2019)

Gastric Cancer Epidemiology in Korea
por: Shin, Aesun, et al.
Publicado: (2011)

Influence of Besifovir Dipivoxil Maleate Combined with L-Carnitine on Hepatic Steatosis in Patients with Chronic Hepatitis B
por: Jung, Yeon Woo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sufqesb6q8i5hfghotpnkqk5t1